French up­start Step Phar­ma rais­es €8.6M, tak­ing im­muno­sup­pres­sive drugs to the clin­ic

Paris start­up Step Phar­ma has scored €8.6 mil­lion in a deal led by a new in­vestor to help bring its small-mol­e­cule im­muno­sup­pres­sive drugs in­to clin­i­cal tri­als for au­toim­mune dis­ease.

The new cash comes in part from Pon­tif­ax Ven­ture Cap­i­tal, and is added to Step’s first tranche of €5.9 mil­lion led by Ku­ma Part­ners last year, bring­ing the start­up’s to­tal Se­ries A raise to €14.5 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER